PINAR TARKUN, Elif Birtaş ATEŞOĞLU, ÖZGÜR MEHTAP, Abdullah HACIHANEFİOĞLU, Hakan KESKİ

POSTPARTUM EDİNSEL HEMOFİLİ A OLAN BİR HASTADA İMMÜNSUPRESSİF TEDAVİ: OLGU SUNUMU

ÖZ

Anahtar Kelimeler:

Edinsel, hemofili A, inhibitör

PDF

___

Feinstein DI (Editor). Hoffman hematology: Basic principles and practice. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P . Inhibitors of blood coagulation. 4th Edition. Pennsylvania: Elsevier, 2005:2143–67.
Baudo F, Caimi T, Cataldo FD. Diagnosis and treatment of acquired haemophilia. Haemophilia 2010;16(102):102–6.
Huth-Kühne A, Baudo F, Collins P, et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 2009;94(4):566–75.
Söhngen D, Specker C, Bach D, et al. Acquired factor VIII inhibitors in nonhemophilic patients. Ann Hematol 1997;74(2):89–93.
Shetty.S, Bhave M, Ghosh K. Acquired hemophilia A: Diagnosis, aetiology, clinical spectrum and treatment options. Autoimmun Rev 2011;10(6):311-6.
Collins P, Baudo F, Huth-Kühne A, et al. Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. . BMC Res Notes 2010;7(3):161.
Green D. Factor VIII inhibitors: a 50- year perspective. Hemophilia 2011;17(6):831–8.
Spero JA, Lewis JH, Hasiba U. Corticosteroid therapy for acquired F VIII:C inhibitors. Br J Haematol 1981;48(4):635-42.
Green D, Rademaker AW, Briet E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 1993;70(5):753-7.
Ma AD, Carrizosa D. Acquired factor VIII inhibitors: pathophiysiology and treatment. American Society of Hematology. Hematology 2006;1(1):432–7.
Collins PW, Hirsch S, Baglin TP, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation. Blood 2007;109 (5):1870-7. 27